Altimmune (ALT) Exchange Rate Effect (2010 - 2018)
Altimmune (ALT) reported Exchange Rate Effect of -$48470.0 for Q2 2018, down 209.77% year-over-year from $44154.0 in Q2 2017, and down 2457.78% quarter-over-quarter from -$1895.0 in Q1 2018.
Altimmune (ALT) Exchange Rate Effect (2010 - 2018) Analysis & Trends
Altimmune (ALT) has 9 years of Exchange Rate Effect data on file, last reported at -$48470.0 in Q2 2018.
- Exchange Rate Effect for Q2 2018 came in at -$48470.0, down 209.77% year-over-year; the trailing twelve-month figure through Dec 2018 was -$50365.0 (down 167.71% YoY), and the FY2018 annual result was -$50365.0, down 167.71% from the prior year.
- Exchange Rate Effect retreated to -$48470.0 in Q2 2018 per ALT's latest filing, from -$1895.0 in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $44154.0 in Q2 2017 and troughed at -$98830.0 in Q2 2016.
- A 5-year average of -$9007.7 and a median of -$1696.0 in 2016 frame the typical range for Exchange Rate Effect.
- The sharpest annual moves came in 2015 and 2016: Exchange Rate Effect jumped 2436.12% in 2015, then sank 13782.14% in 2016.
- A 5-year view of Exchange Rate Effect shows it stood at -$5256.0 in 2014, then surged by 63.01% to -$1944.0 in 2015, then advanced by 22.99% to -$1497.0 in 2016, then slumped by 734.47% to -$12492.0 in 2017, then plunged by 288.01% to -$48470.0 in 2018.
- Business Quant data shows ALT's Exchange Rate Effect at -$48470.0 in Q2 2018, -$1895.0 in Q1 2018, and -$12492.0 in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 8.68 Mn |
| 10 | Altimmune | 336.67 Mn | 336.67 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2018 | -48,470.00 |
| Jun 30, 2018 | -48,470.00 |
| Mar 31, 2018 | -1,895.00 |
| Mar 31, 2018 | -1,895.00 |
| Dec 31, 2017 | -12,492.00 |
| Dec 31, 2017 | -12,492.00 |
| Sep 30, 2017 | 35,326.00 |
| Sep 30, 2017 | 35,326.00 |
| Jun 30, 2017 | 44,154.00 |
| Jun 30, 2017 | 44,154.00 |
| Mar 31, 2017 | 7,399.00 |
| Mar 31, 2017 | 7,399.00 |
| Dec 31, 2016 | -1,497.00 |
| Dec 31, 2016 | -1,497.00 |
| Sep 30, 2016 | -69,966.00 |
| Sep 30, 2016 | -69,966.00 |
| Jun 30, 2016 | -98,830.00 |
| Jun 30, 2016 | -98,830.00 |
| Mar 31, 2016 | -1,252.00 |
| Mar 31, 2016 | -1,252.00 |